Загрузка...

Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer

BACKGROUND: The objective of this study was to discover and to validate novel noninvasive biomarkers that distinguish between benign prostate hyperplasia (BPH) and localized prostate cancer (PCa), thereby helping to solve the diagnostic dilemma confronting clinicians who treat these patients. METHOD...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMC Cancer
Главные авторы: Jedinak, Andrej, Curatolo, Adam, Zurakowski, David, Dillon, Simon, Bhasin, Manoj K, Libermann, Towia A, Roy, Roopali, Sachdev, Monisha, Loughlin, Kevin R, Moses, Marsha A
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2015
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4433087/
https://ncbi.nlm.nih.gov/pubmed/25884438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1284-z
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!